/term/cyclically-adjusted-fcf/XKRX:042520 Hans Biomed (XKRX:042520) Cyclically Adjusted FCF per Share
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hans Biomed Corp (XKRX:042520) » Definitions » Cyclically Adjusted FCF per Share

Hans Biomed (XKRX:042520) Cyclically Adjusted FCF per Share : ₩-834.66 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Hans Biomed Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Hans Biomed's adjusted free cash flow per share for the three months ended in Mar. 2024 was ₩44.556. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩-834.66 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -17.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Hans Biomed was -17.70% per year. The lowest was -22.00% per year. And the median was -19.85% per year.

As of today (2024-06-20), Hans Biomed's current stock price is ₩12260.00. Hans Biomed's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ₩-834.66. Hans Biomed's Cyclically Adjusted Price-to-FCF of today is .

Hans Biomed Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Hans Biomed's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hans Biomed Cyclically Adjusted FCF per Share Chart

Hans Biomed Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -470.22 -526.39 -732.82 -854.39 -857.88

Hans Biomed Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -881.15 -890.06 -857.88 -861.70 -834.66

Competitive Comparison of Hans Biomed's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Hans Biomed's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hans Biomed's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hans Biomed's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Hans Biomed's Cyclically Adjusted Price-to-FCF falls into.


Hans Biomed Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hans Biomed's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=44.556/118.8477*118.8477
=44.556

Current CPI (Mar. 2024) = 118.8477.

Hans Biomed Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -1,070.469 99.353 -1,280.513
201409 11.049 99.608 13.183
201412 44.242 99.098 53.059
201503 -133.244 99.720 -158.802
201506 -15.514 100.050 -18.429
201509 -171.414 100.110 -203.498
201512 -62.456 100.220 -74.065
201603 -218.509 100.560 -258.247
201606 -294.960 100.790 -347.806
201609 -489.057 101.460 -572.869
201612 -642.075 101.560 -751.370
201703 -41.369 102.850 -47.804
201706 59.299 102.610 68.683
201709 -259.346 103.490 -297.832
201712 52.269 102.990 60.317
201803 209.267 104.100 238.914
201806 116.945 104.130 133.474
201809 -125.361 105.650 -141.021
201812 68.274 104.350 77.760
201903 -408.165 104.490 -464.250
201906 -599.927 104.880 -679.824
201909 54.539 105.200 61.614
201912 -18.013 105.120 -20.365
202003 -170.194 105.540 -191.654
202006 -252.759 104.870 -286.448
202009 89.415 106.200 100.064
202012 -370.643 105.765 -416.488
202103 -587.993 107.357 -650.926
202106 -398.780 107.579 -440.553
202109 -624.400 108.759 -682.319
202112 -263.339 109.676 -285.360
202203 -15.434 111.806 -16.406
202206 -165.652 114.083 -172.571
202209 -208.150 114.831 -215.430
202212 -67.960 115.200 -70.112
202303 -207.047 116.550 -211.130
202306 -158.178 117.140 -160.484
202309 -115.522 119.111 -115.266
202312 33.611 118.848 33.611
202403 44.556 118.848 44.556

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Hans Biomed  (XKRX:042520) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.

Hans Biomed Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Hans Biomed's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Hans Biomed (XKRX:042520) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hans Biomed Corp (XKRX:042520) » Definitions » Cyclically Adjusted FCF per Share
Comparable Companies
XKRX:208370 XKRX:065510 XKRX:228850 XKRX:164060 XKRX:246710 XKRX:156100 XKRX:104540 XKRX:004080 XKRX:241820 XKRX:263690 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
8th Floor SK Building 16-4, Sungsu 1 ga Dong, Sungdong-gu, Seoul, KOR
Website
http://www.hansbiomed.com
Hans Biomed Corp manufactures and markets bioengineering products. The company manufactures artificial skin for a skin graft, various bones mainly for dental implants and joints and medical silicone.

Hans Biomed (XKRX:042520) Headlines

No Headlines